It wasn't negative as much as it was realistic. There are some real challenges to be met before this thing develops into a homerun.
Interesting thoughts, and worth discussion.
Totally true, $20 million isn't much VC capital to be used in advanced cycle companies (last round of financing before IPO, for example). That thought has certainly occurred to me.
I disagree that the whole Internet thing is now so mature that basically the opportunities are almost gone, forcing JDX to invest in advanced stage companies or lose out by being left behine. There's a lot of change happening, and a lot yet left to develop, expand, mature, invent, and so on.
If the depth of the VC pool is such a detriment, why did Bill Staudt ever join this company? It wasn't altruism, for sure. Anyone who comes to a company like this at this stage does so because they see a big reward at the end, via a terrific return in stock gains. If Bill Staudt, the man with all the goodwill and good connections, didn't go to an American VC company or startup with a deeper pool of capital I'll assume it's because he's confident in this decision.
Further, Medsite, gift or not, will bring attention to Jordex. And if Bill has so much goodwill built up, it would seem that should pay off in other opportunities as well.
IMO
WUWT |
